A Fluorescence-Based Assay for Measuring Glucose Uptake in Living Melanoma Cells
Authors:
- 25 October 2026
- book chapter
- Published by Springer Nature
- Vol. 3089, 73-83
Abstract
Melanoma cells have high glycolytic capacity. Glucose uptake is a key rate-limiting step in glucose utilization. Here we describe a simple protocol for measuring direct glucose uptake in living melanoma cells by flow cytometry.Keywords
This publication has 16 references indexed in Scilit:
- Repurposing old drugs to fight multidrug resistant cancersDrug Resistance Updates, 2020
- Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanomaCancer Letters, 2019
- Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implicationsPigment Cell & Melanoma Research, 2017
- Nile Red and 2-NBDG Are Incompatible for the Simultaneous Detection of Lipid and Glucose AccumulationInternational Journal of Spectroscopy, 2016
- Molecular drivers of cellular metabolic reprogramming in melanomaTrends in Molecular Medicine, 2015
- Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating Oxidative PhosphorylationClinical Cancer Research, 2014
- 2-NBDG as a fluorescent indicator for direct glucose uptake measurementJournal of Biochemical and Biophysical Methods, 2005
- A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coliBiochimica et Biophysica Acta (BBA) - General Subjects, 1996
- Intracellular Fate of 2-NBDG, a Fluorescent Probe for Glucose Uptake Activity, inEscherichia coliCellsBioscience, Biotechnology, and Biochemistry, 1996
- Regulation of glucose transport by pioglitazone in cultured muscle cellsMetabolism, 1994